SCHEMBL3628035

SCHEMBL3628035

C[S+](C)C.O=P(O)(O)F.O=P(O)(O)F.O=P(O)(O)F.O=P(O)(O)F.O=P(O)(O)F.O=P([O-])(O)F

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.41
FDPS P14324 3/20 0.37
GGPS1 O95749 2/20 0.37
CA2 P00918 1/20 0.35
KDM4E B2RXH2 1/20 0.30
CYP2C19 P33261 1/20 0.30
KMT2A Q03164 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethyl Sulfoxide SCHEMBL16497660 0.83 CA2 (0.38) SLC34A1FDPSGGPS1CA2
Tetramethylammonium Ion SCHEMBL1130116 0.80 SLC34A1 (0.41) SLC34A1CA2KDM4ECYP2C19KMT2A
SCHEMBL28492233 0.79 SLC34A1 (0.47) SLC34A1CA2KDM4ECYP2C19KMT2A
Lithium Ion SCHEMBL28390201 0.78
SCHEMBL583553 0.78
Ammonia Solution, Strong SCHEMBL7594155 0.76 SLC34A1 (0.53) SLC34A1KDM4ECYP2C19KMT2ALMNA
Lithium Ion SCHEMBL29135346 0.74 SLC34A1 (0.50) SLC34A1FDPSGGPS1CA2KDM4E
SCHEMBL29167943 0.74 SLC34A1 (0.50) SLC34A1FDPSGGPS1CA2KDM4E
Ammonia Solution, Strong SCHEMBL1289336 0.74
Fluoride Ion SCHEMBL1708173 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210347941-A1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS (US) 2021-11-11 US claimed
US-20190055354-A1 METHODS FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS 2019-02-21 US claimed
US-20170073468-A1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS 2017-03-16 US claimed
US-8604159-B2 Method for preparing functionalized polymers from polymer alcohols NEKTAR THERAPEUTICS (US) 2013-12-10 US claimed
EP-1656410-B1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS (US) 2010-03-10 EP claimed
EP-1656410-A2 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS Nektar Therapeutics Al, Corporation (US) 2006-05-17 EP claimed
US-20050054816-A1 Method for preparing functionalized polymers from polymer alcohols NEKTAR THERAPEUTICS 2005-03-10 US claimed
WO-2005010075-A2 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS AL, CORPORATION (US) 2005-02-03 WO claimed
US-20210347941-A1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS (US) 2021-11-11 US disclosed
US-10941248-B2 Methods for preparing functionalized polymers from polymer alcohols NEKTAR THERAPEUTICS (US) 2021-03-09 US disclosed
US-20190055354-A1 METHODS FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS 2019-02-21 US disclosed
US-10144804-B2 Method for preparing functionalized polymers from polymer alcohols NEKTAR THERAPEUTICS (US) 2018-12-04 US disclosed
US-20170073468-A1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS 2017-03-16 US disclosed
US-20140073802-A1 MALEIMIDYL POLYMER DERIVATIVES NEKTAR THERAPEUTICS (US) 2014-03-13 US disclosed
US-8604159-B2 Method for preparing functionalized polymers from polymer alcohols NEKTAR THERAPEUTICS (US) 2013-12-10 US disclosed
EP-1656410-B1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS (US) 2010-03-10 EP disclosed
EP-1656410-A2 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS Nektar Therapeutics Al, Corporation (US) 2006-05-17 EP disclosed
US-20050054816-A1 Method for preparing functionalized polymers from polymer alcohols NEKTAR THERAPEUTICS 2005-03-10 US disclosed
WO-2005010075-A2 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS AL, CORPORATION (US) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210347941-A1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS ADH1C, ADH1A, ADH5 SLC34A1 3609/4885FDPS 1048/4885GGPS1 808/4885
US-10144804-B2 Method for preparing functionalized polymers from polymer alcohols ADH1C, ADH1A, ADH5 SLC34A1 2417/4885FDPS 563/4885GGPS1 1486/4885
US-20190055354-A1 METHODS FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS ADH1C, ADH1A, ADH5 SLC34A1 2511/4885FDPS 835/4885GGPS1 1788/4885
US-10941248-B2 Methods for preparing functionalized polymers from polymer alcohols ADH1C, ADH1A, ADH5 SLC34A1 2511/4885FDPS 835/4885GGPS1 1788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.